Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
Search by expertise, name or affiliation
Long‐term Treatment of Systemic Mastocytosis with Histamine H
2
Receptor Antagonists
GERHARD J. JOHNSON
, STEPHEN E. SILVIS
, BEATRICE ROITMAN
, MALCOLM BLUMENTHAL
, HARRIET S. GILBERT
Research output
:
Contribution to journal
›
Article
›
peer-review
30
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Long‐term Treatment of Systemic Mastocytosis with Histamine H
2
Receptor Antagonists'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Long-term Treatment
100%
Cimetidine
100%
Histamine-2 Receptor Antagonists (H2RA)
100%
Systemic Mastocytosis
100%
Hypersecretion
50%
Mastocytosis
33%
Cutaneous Symptoms
33%
Healing
16%
Leukocytes
16%
Ulcer
16%
Histamine
16%
Vitamin B12
16%
Histamine Release
16%
Duodenal Ulcer
16%
Histamine H2 Receptor
16%
Pharmacology, Toxicology and Pharmaceutical Science
Cimetidine
100%
Systemic Mastocytosis
100%
Histamine H2 Receptor Antagonist
100%
Histamine
33%
Mastocytosis
33%
Vitamin B12
16%
Ulcer
16%
Recurrent Disease
16%
Metiamide
16%
Duodenum Ulcer
16%
Histamine H2 Receptor
16%